Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Ankylosing Spondylitis (AS) With Etanercept

NCT04507763 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04507763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04507763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Ankylosing Spondylitis (AS) With Etanercept
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 1, 2020
Completion date
October 1, 2020
Enrollment
763 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis